Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical-trial record for the XMT-1536 study is displayed, including its study design, participant criteria, treatment arms, outcome measures, and record dates.
    Difference
    56%
    Check dated 2026-11-11T01:40:55.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:55:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page. The displayed site revision also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:59:25.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The footer displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T00:13:01.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous study content. This indicates the study record is currently inaccessible.
    Difference
    20%
    Check dated 2026-09-23T00:09:27.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an underlying update to the page version behind the study details.
    Difference
    0.1%
    Check dated 2026-09-16T00:23:00.000Z thumbnail image

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.